These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3449871)

  • 1. Measurement of subclinical changes during lithium prophylaxis: a longitudinal study.
    Molnar G; Fava GA; Zielezny M; Spinks MT; Loretan A
    Psychopathology; 1987; 20(3-4):155-61. PubMed ID: 3449871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives.
    Bocchetta A; Bernardi F; Burrai C; Pedditzi M; Del Zompo M
    Acta Psychiatr Scand; 1993 Dec; 88(6):434-9. PubMed ID: 8310852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
    Maj M; Pirozzi R; Magliano L; Bartoli L
    Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.
    Chand PK; Mattoo SK; Sharan P
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):311-8. PubMed ID: 15149299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder.
    Maj M; Arena F; Lovero N; Pirozzi R; Kemali D
    Pharmacopsychiatry; 1985 Sep; 18(5):309-13. PubMed ID: 3931108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patients.
    Jann MW; Bitar AH; Rao A
    Am J Psychiatry; 1982 May; 139(5):683-4. PubMed ID: 7072862
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a loss of efficacy of lithium in patients treated for over 20 years?
    Berghöfer A; Müller-Oerlinghausen B
    Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long term prophylaxis of affective disorders.
    Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
    Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma lithium level and interepisode functioning in bipolar disorder.
    Goodnick PJ; Fieve RR
    Am J Psychiatry; 1985 Jun; 142(6):761-2. PubMed ID: 4003601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study.
    Strober M; Morrell W; Lampert C; Burroughs J
    Am J Psychiatry; 1990 Apr; 147(4):457-61. PubMed ID: 2107763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs in dermatologic practice.
    Crayton JW; Freedman DX
    Int J Dermatol; 1977; 16(6):512-9. PubMed ID: 892960
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonazepam vs. neuroleptics as adjuncts to lithium maintenance.
    Sachs GS; Weilburg JB; Rosenbaum JF
    Psychopharmacol Bull; 1990; 26(1):137-43. PubMed ID: 1973545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium prophylaxis in recurrent affective illness.
    Prien RF; Klett CJ; Caffey EM
    Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder.
    Fieve RR; Platman SR; Plutchik RR
    Am J Psychiatry; 1968 Oct; 125(4):492-8. PubMed ID: 4886103
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosensory symptoms in bipolar disorder.
    Ali SO; Denicoff KD; Ketter TA; Smith-Jackson EE; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):223-31. PubMed ID: 9359118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine for treatment-refractory mania.
    Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
    Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.